Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 14/20 | 0.68 |
| ▸ | SCN5A | Q14524 | 10/20 | 0.68 |
| ▸ | KCNH2 | Q12809 | 9/20 | 0.64 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.58 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.58 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.58 |
| ▸ | BRS3 | P32247 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3955691 | 0.83 | SCN9A (0.82) | SCN9ASCN5AKCNH2KCNQ2KCNA5 | |
| SCHEMBL3750100 | 0.83 | KMT2A (0.55) | SCN9ASCN5AKCNH2KCNA5KMT2A | |
| SCHEMBL3892016 | 0.81 | SCN9A (0.75) | SCN9ASCN5AKCNH2KCNQ2KCNA5 | |
| SCHEMBL3890678 | 0.81 | SCN9A (1.00) | SCN9ASCN5AKCNH2KCNQ2KCNA5 | |
| SCHEMBL13568303 | 0.81 | SCN9A (0.67) | SCN9ASCN5AKCNH2KCNQ2KCNA5 | |
| SCHEMBL3747848 | 0.81 | KCNA5 (0.56) | KCNH2KCNA5BRS3KMT2ATP53 | |
| SCHEMBL3755739 | 0.81 | KMT2A (0.59) | KCNH2KCNA5BRS3KMT2ATP53 | |
| SCHEMBL3892334 | 0.80 | SCN9A (0.86) | SCN9ASCN5AKCNH2KCNQ2KCNA5 | |
| SCHEMBL3897275 | 0.79 | SCN9A (0.57) | SCN9ASCN5AKCNH2KCNQ2KCNA5 | |
| SCHEMBL3753733 | 0.79 | ALDH1A1 (0.62) | SCN9ASCN5AKCNH2KCNA5KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009145718-A1 | ISOINDOLINE DERIVATIVES COMPRISING AN ADDITIONAL HETEROCYCLIC GROUP AND THEIR USE IN THE TREATMENT OF PAIN DISORDERS | ASTRAZENECA AB (SE) | 2009-12-03 | — | — | WO | disclosed |